Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRB2 | P62993 | 1/20 | 0.49 |
| ▸ | CALCRL | Q16602 | 4/20 | 0.48 |
| ▸ | CTSD | P07339 | 2/20 | 0.44 |
| ▸ | BACE1 | P56817 | 2/20 | 0.44 |
| ▸ | AGTR2 | P50052 | 5/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 4/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | CMA1 | P23946 | 2/20 | 0.43 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.43 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.42 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29641650 | 1.00 | GRB2 (0.49) | GRB2CALCRLCTSDBACE1AGTR2 | |
| SCHEMBL30150546 | 0.94 | GRB2 (0.52) | GRB2CALCRLAGTR2AGTR1SLC6A2 | |
| SCHEMBL29641795 | 0.88 | CALCRL (0.60) | CALCRLAGTR2AGTR1SLC6A2CMA1 | |
| SCHEMBL29641778 | 0.87 | XIAP (0.47) | GRB2CALCRLSLC6A2CMA1 | |
| SCHEMBL30123263 | 0.86 | SLC6A2 (0.52) | CALCRLSLC6A2CMA1CAPN1OPRM1 | |
| SCHEMBL29641646 | 0.85 | GRB2 (0.48) | GRB2CALCRLCTSDBACE1AGTR2 | |
| SCHEMBL29865847 | 0.85 | GRB2 (0.48) | GRB2CTSDBACE1CAPN1 | |
| SCHEMBL29662278 | 0.85 | OPRM1 (0.46) | GRB2CALCRLSLC6A2OPRM1 | |
| SCHEMBL30753842 | 0.84 | SLC6A2 (0.53) | CALCRLSLC6A2CMA1CAPN1OPRM1 | |
| SCHEMBL29838219 | 0.84 | GRB2 (0.46) | GRB2SLC6A2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220089719-A1 | CONSTRUCTS TARGETING LABYRINTHIN OR A PORTION THEREOF AND USES THEREOF | LABYRX IMMUNOLOGIC THERAPEUTICS (USA) LIMITED (US) | 2022-03-24 | — | — | US | disclosed |